Reappraisal of duct-to-duct biliary reconstruction in hepatic resection for liver tumors

2007 ◽  
Vol 194 (3) ◽  
pp. 283-287 ◽  
Author(s):  
Takuya Hashimoto ◽  
Norihiro Kokudo ◽  
Kiyoshi Hasegawa ◽  
Keiji Sano ◽  
Hiroshi Imamura ◽  
...  
1984 ◽  
Vol 2 (6) ◽  
pp. 637-642 ◽  
Author(s):  
R Mittal ◽  
C Kowal ◽  
T Starzl ◽  
D Van Thiel ◽  
K Bron ◽  
...  

Computerized tomography (CT) of liver is used in oncologic practice for staging tumors, evaluating response to treatment, and screening patients for hepatic resection. Because of the impact of CT liver scan on major treatment decisions, it is important to assess its accuracy. Patients undergoing liver transplantation or resection provide a unique opportunity to test the accuracy of hepatic-imaging techniques by comparison of findings of preoperative CT scan with those at gross pathologic examination of resected specimens. Forty-one patients who had partial hepatic resection (34 patients) or liver transplantation (eight patients) for malignant (30 patients) or benign (11 patients) tumors were evaluable. Eight (47%) of 17 patients with primary malignant liver tumors, four (31%) of 13 patients with metastatic liver tumors, and two (20%) of 10 patients with benign liver tumors had tumor nodules in resected specimens that were not apparent on preoperative CT studies. These nodules varied in size from 0.1 to 1.6 cm. While 11 of 14 of these nodules were less than 1.0 cm, three of 14 were greater than 1.0 cm. These results suggest that conventional CT alone may be insufficient to accurately determine the presence or absence of liver metastases, extent of liver involvement, or response of hepatic metastases to treatment.


Author(s):  
Vani M. ◽  
Jeena Sam Kachappilly ◽  
Geetha K.

Background: Hepatic resections are done for both neoplastic and non-neoplastic diseases of liver with malignancies constituting a major share of cases. The objective of this study was to assess the various neoplatic and non-neoplastic lesions in hepatic resection specimens and to categorize the various histopathological types of primary and secondary liver tumors.Methods: The study was conducted in the Department of Pathology, Academy of Medical sciences, Pariyaram. This was a hospital based study which included 79 patients who underwent hepatic resection for space occupying lesions over a period of 5 years from January 2012 to December 2016. IHC was performed in cases with diagnostic dilemma.Results: Of the 79 cases, there were 45 males and 34 females with the age range of 22-85 years. There were 70 neoplastic lesions out of which 11 were benign with 6 cavernous hemangiomas, 3 hepatic adenomas and one each of intraductal papillary neoplasm and mucinous cystic neoplasm. Among the 59 malignant lesions, hepatocellular carcinomas predominated followed by metastatic malignancies and cholangiocarcinomas. Of the metastatic malignancies, adenocarcinoma from gastrointestinal primary was the commonest followed by metastatic gastrointestinal stromal tumor.Conclusions: Liver is a frequent site for many neoplastic and non-neoplastic diseases with malignant neoplasms forming the major bulk. Non-neoplastic lesions like simple liver cysts and focal nodular hyperplasia showed female predominance while benign neoplasms like cavernous hemangioma and hepatic adenomas were seen exclusively in females. Of the malignant liver tumors, hepatocellular carcinoma was the commonest followed by metastatic malignancy, gastrointestinal tract being the commonest source of primary tumor.


2019 ◽  
Vol 23 (11) ◽  
pp. 2314-2321 ◽  
Author(s):  
Yoshihiro Inoue ◽  
Kensuke Fujii ◽  
Masatsugu Ishii ◽  
Syuji Kagota ◽  
Atsushi Tomioka ◽  
...  

2004 ◽  
Vol 10 (S2) ◽  
pp. S30-S33 ◽  
Author(s):  
Guido Torzilli ◽  
Natale Olivari ◽  
Daniele Del Fabbro ◽  
Piera Leoni ◽  
Adele Gendarini ◽  
...  

2019 ◽  
Vol 28 (4) ◽  
pp. 763-782 ◽  
Author(s):  
Tiffany C. Lee ◽  
Mackenzie C. Morris ◽  
Sameer H. Patel ◽  
Shimul A. Shah

Author(s):  
Toshiyuki Itamoto ◽  
Koji Katayama ◽  
Yoshio Miura ◽  
Hiroshi Hino ◽  
Hideki Ohdan ◽  
...  

2018 ◽  
Vol 108 (3) ◽  
pp. 194-200 ◽  
Author(s):  
M. Papamichail ◽  
K. Marmagkiolis ◽  
M. Pizanias ◽  
C. Koutserimpas ◽  
N. Heaton

Background and Aims: Patients with liver tumors involving the inferior vena cava have a poor outcome without surgery. Liver resection en bloc with inferior vena cava resection and reconstruction is now performed in many centers. The purpose of this study is to investigate the safety and efficacy of inferior vena cava reconstruction during hepatic resection. Materials and Methods: A review of 12 centers reporting 240 patients with combined hepatectomy and inferior vena cava resection and reconstruction for malignant tumors was performed. Sample size, patient characteristics, histological type of the tumor, method of reconstruction, complications, and long-term survival (1-, 2-, and 5-year survival) were evaluated. Results: A total of 240 patients from 12 institutions (male 58%) with mean age 54 years underwent combined liver resection and inferior vena cava resection and reconstruction for colorectal liver metastases (43%), cholangiocarcinomas (26%), hepatocellular carcinomas (19%), leiomyosarcomas (4%), and other tumors (7.9%). Reconstruction included primary closure (35.8%), patch repair (13.3%), or interposition graft (50.8%) In-hospital mortality was 6.25% and overall morbidity was 42.1%. 1- and 10-year survival rates were 79.7% and 28.9%, respectively. Conclusion: Tumors arising in or extending to inferior vena cava that require liver resection should be considered for surgery as it can be performed with an acceptable mortality and morbidity in centers with liver transplantation and hepato-pancreato-biliary facilities.


HPB Surgery ◽  
1992 ◽  
Vol 5 (2) ◽  
pp. 87-94 ◽  
Author(s):  
Anatoly M. Granov ◽  
Pavel G. Tarazov ◽  
Vladimir K. Ryzhkov

Prognosis of 16 patients with hepatic tumors and angiographically proven arterioportal fistulas was analysed in relation to treatment. Six patients received only conservative therapy; they all died of variceal bleeding in the course of two months after angiography. Hepatic resection was performed in four patients; three of them are still alive 13–52 months later including two free of both the tumor and portal hypertension. Hepatic artery embolization was carried out in six patients. All of them died in 2–36 months after the procedure, but only two from gastroesophageal hemorrhage. It is concluded that prognosis of arterioportal fistulae in liver neoplasms is poor due to hyperkinetic portal hypertension and following variceal bleeding. Hepatic resection of both the tumor and the fistula is the treatment of choice. In unresectable cases hepatic artery embolization will decrease the risk of variceal hemorrhage.


Sign in / Sign up

Export Citation Format

Share Document